PharmaVault
گنجینه اطلاعات داروسازی
The Pharmaceutical Information Vault
Excipient monograph · مونوگراف ماده جانبی
pharmavault.ir
Carbomer
کاربومر، کاربوپل
1Nonproprietary names
- BPCarbomers
- Ph. Eur.Carbomers
- USP–NFCarbomer Homopolymer; Carbomer Copolymer; Carbomer Interpolymer
2Synonyms and trade names
Acritamer; acrylic acid polymer; carbomera; Carbopol; carboxy polymethylene; carboxyvinyl polymer; Pemulen; polyacrylic acid; Tego Carbomer
3Chemical name and CAS Registry Number
High-molecular-weight polymers of acrylic acid crosslinked with allyl ethers of sucrose or pentaerythritol · [9003-01-4]
4Empirical formula and molecular weight
(C3H4O2)n (repeat unit) · estimated 7 × 10⁵ to 4 × 10⁹
5Functional category
Gelling agent, viscosity modifier
Typical concentrations: 0.5–2% gel · 0.5–1% suspending · 0.1–0.5% emulsifying · Dosage forms: Semi-solid, Liquid
6Applications in pharmaceutical formulation
Used mainly as rheology modifiers in liquid and semisolid preparations, such as gels, creams, lotions and suspensions, including ophthalmic, rectal, topical and vaginal products. Some grades act as primary polymeric emulsifiers, and carbomers are also used as tablet binders, controlled-release matrix formers and bioadhesives. Typical concentrations: emulsifying agent 0.1–0.5%; gelling agent 0.5–2.0%; suspending agent 0.5–1.0%; tablet binder 0.75–3.0%; controlled-release agent 5.0–30.0%.
7Description
A white, fluffy, acidic, hygroscopic powder with a slight characteristic odour. Grades differ in crosslink density, polymerisation solvent and the viscosity they give when neutralised.
8Typical properties
- Carboxylic acid content
- 56.0–68.0% (dried substance)
- pKa
- ≈ 6.0 ± 0.5
- pH
- ≈ 2.5–3.5 (0.5–1% w/v aqueous dispersion)
- Viscosity
- low as an acidic dispersion; rises sharply on neutralisation, with the level depending on grade and concentration
- Moisture content
- hygroscopic; typically not more than 2% as supplied
- Solubility
- does not dissolve but swells in water, glycerol and, after neutralisation, ethanol (95%)
9Stability and storage conditions
The dry powder is stable and does not support microbial growth, but aqueous gels do and need a preservative. Gels lose viscosity on prolonged exposure to light; this is reduced by adding an antioxidant or a chelating agent such as edetate. Store in an airtight container in a cool, dry place.
10Incompatibilities
Discoloured by resorcinol and incompatible with phenol, cationic polymers, strong acids and high concentrations of electrolytes, which reduce gel viscosity. Trace iron and other transition metals catalyse its degradation, and cationic drugs may form insoluble complexes.
11Method of manufacture
Made by polymerising acrylic acid with a polyalkenyl ether crosslinker in an organic solvent. Older grades were polymerised in benzene; current grades use ethyl acetate or cyclohexane–ethyl acetate mixtures.
12Safety
Regarded as essentially non-toxic and non-irritant when used in topical and oral products; its high molecular weight prevents absorption. The powder can irritate the eyes.
13Handling precautions
The dust may irritate the eyes, mucous membranes and respiratory tract. Wear gloves, eye protection and a dust respirator, and avoid creating airborne dust.
14Regulatory status
Included in the FDA Inactive Ingredient Database (ophthalmic, oral, rectal, topical and vaginal preparations) and in non-parenteral medicines licensed in Europe.
15Related substances
Polycarbophil; calcium polycarbophil; polyacrylates.
16Comments
Disperse the powder slowly into vigorously stirred water to avoid lumps, then neutralise with a base such as sodium hydroxide, triethanolamine or trometamol; maximum viscosity is usually reached around pH 6–7.5. Grades polymerised in benzene are subject to residual-solvent limits and have largely been replaced.